S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for first-line treatment of patients with metastatic colorectal cancer: a randomised, non-inferiority phase 3 trial
Work
Year: 2012
Type: article
Source: The Lancet Oncology
Institutions University of Ulsan, Ulsan College, Sungkyunkwan University, National Cancer Center, Seoul National University Bundang Hospital +7 more
Cites: 33
Cited by: 120
Related to: 10
FWCI: 5.724
Citation percentile (by year/subfield): 94.02
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: closed